![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: McClung Colleen A
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.8, Iss.9, 2007-09, pp. : 1097-1100
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Efficacy of maintenance therapy in bipolar disorder re-examined
Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cognitive therapy "highly cost-effective" in bipolar disorder
Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Long-term lithium therapy reduces the risk of relapse in patients with bipolar disorder
Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quetiapine: single-drug therapy for bipolar disorder?
Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. :